RxDoctor Payments Data

Daniel Glade, MD

Dermatology · Lehi, UTNPI 1821618430

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,596 of the $4,267 with a category attached, or 84.3%. 25 manufacturers reported payments, led by AbbVie at 32.3% of the total.

$4,267in general payments, 2019–2025

Across 141 payments — averaging $30.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$363
  • Arcutis Biotherapeutics, Inc.$337
  • Sanofi$308
  • Galderma Laboratories, L.p.$211
  • Lilly USA, LLC$204
  • plus $1K from 19 others

What the payments were for

  • Travel & lodging$47311%
  • Food & beverage$3,59684%
  • Education$1985%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,267 in reported general payments places this provider in the 70th percentile of 163 dermatology providers in Utah.

See all dermatology providers in Utah

Medicare billing

Part B allowed, 2024
$30,027
Medicare patients
151
Services billed
356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate22$1,472
Clindamycin Phosphate25$977
Ketoconazole46$813
Triamcinolone Acetonide41$441
Doxycycline Hyclate11$232
Mupirocin17$54

Paid to pharmacies, not to this prescriber.

Other dermatology in Lehi

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →